Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Coronary Artery Disease
  • Immunoglobulin Fab Fragments
  • Myocardial Ischemia
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Stents

abstract

  • The combination of stenting and abciximab during percutaneous coronary interventions for patients with angiographically complex lesions confers additive long-term benefit with respect to death, myocardial infarction, and target vessel revascularization.

publication date

  • July 4, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10880411

Additional Document Info

start page

  • 28

end page

  • 34

volume

  • 102

number

  • 1